Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127620411 | 12762041 | 1 | I | 20011114 | 20020402 | 20160920 | 20160920 | EXP | JP-OTSUKA-02100-JPN-02-0028 | OTSUKA | 95.10 | YR | F | Y | 45.00000 | KG | 20160920 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127620411 | 12762041 | 1 | PS | Pletaal tablets 50mg | CILOSTAZOL | 1 | Oral | 100 MG, BID | 36000 | MG | D | 20863 | 100 | MG | TABLET | BID | |||
| 127620411 | 12762041 | 2 | SS | Pletaal tablets 50mg | CILOSTAZOL | 1 | Oral | 100 MG, BID | 36000 | MG | D | 20863 | 100 | MG | TABLET | BID | |||
| 127620411 | 12762041 | 3 | SS | ANPLAG | SARPOGRELATE | 1 | Oral | 100 MG, TID | Y | N | 0 | 100 | MG | TABLET | TID | ||||
| 127620411 | 12762041 | 4 | SS | ANPLAG | SARPOGRELATE | 1 | Oral | 100 MG, TID | Y | N | 0 | 100 | MG | TABLET | TID | ||||
| 127620411 | 12762041 | 5 | SS | GASTER | FAMOTIDINE | 1 | Oral | 20 MG, BID | Y | N | 0 | 20 | MG | BID | |||||
| 127620411 | 12762041 | 6 | SS | GASTER | FAMOTIDINE | 1 | Oral | 20 MG, BID | Y | N | 0 | 20 | MG | BID | |||||
| 127620411 | 12762041 | 7 | C | FRANDOL S | ISOSORBIDE DINITRATE | 1 | Transdermal | 40 MG, QID | 0 | 40 | MG | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127620411 | 12762041 | 1 | Peripheral arterial occlusive disease |
| 127620411 | 12762041 | 3 | Product used for unknown indication |
| 127620411 | 12762041 | 5 | Product used for unknown indication |
| 127620411 | 12762041 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127620411 | 12762041 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127620411 | 12762041 | Hepatic cyst | |
| 127620411 | 12762041 | Hepatic function abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127620411 | 12762041 | 1 | 20010518 | 20011115 | 0 | |
| 127620411 | 12762041 | 2 | 20011124 | 20011129 | 0 | |
| 127620411 | 12762041 | 3 | 20010518 | 20011115 | 0 | |
| 127620411 | 12762041 | 4 | 20011124 | 20011129 | 0 | |
| 127620411 | 12762041 | 5 | 20010518 | 20011115 | 0 | |
| 127620411 | 12762041 | 6 | 20011124 | 20011129 | 0 | |
| 127620411 | 12762041 | 7 | 20010505 | 0 |